You are here

Article Text

Article menu
Download PDFPDF
Letter
Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
  1. T Poynard
  1. Service d’Hepato-gastroenterologie Groupe Hospitalier, Pittie-Salpetriere 75651, Paris, France; tpoynard@teaser.fr

https://doi.org/10.1136/gut.52.10.1532

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    I read with great interest the excellent cost effectiveness analysis of pegylated interferon alpha 2b and ribavirin combination in patients with chronic hepatitis C (

    ). I was surprised by the relatively low cost of treatment initiation in Germany (table 3). The cost estimate of pre-therapeutic …

    View Full Text